Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Juva Life Inc. has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 2 distinct examiners and 2 distinct art units, indicating separate examination paths across the pending portfolio.
ENGLISH, CONNOR KENNEDY is the busiest examiner, with 1 pending matter. Since the assignments are evenly distributed, counsel should evaluate each prosecution record independently while maintaining a coordinated position on recurring technical issues.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ENGLISH, CONNOR KENNEDY | 1 | 59.3% | +50.3% |
| PIHONAK, SARAH | 1 | 61.4% | +42.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694378 | CANNABIGEROQUINONE COMPOUNDS, COMPOSITIONS INCLUDING SUCH COMPOUNDS, AND USES OF SUCH COMPOUNDS AND COMPOSITIONS | PIHONAK, SARAH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18717962 | CANNABICHROMENEQUINONE AND ANALOGUES THEREOF, AND METHOD OF USING COMPOSITIONS THEREOF AS ANTI-INFLAMMATORY AGENTS | ENGLISH, CONNOR KENNEDY | — |
| 18694378 | CANNABIGEROQUINONE COMPOUNDS, COMPOSITIONS INCLUDING SUCH COMPOUNDS, AND USES OF SUCH COMPOUNDS AND COMPOSITIONS | PIHONAK, SARAH | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1627 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18717962 | CANNABICHROMENEQUINONE AND ANALOGUES THEREOF, AND METHOD OF USING COMPOSITIONS THEREOF AS ANTI-INFLAMMATORY AGENTS | ENGLISH, CONNOR KENNEDY | 1625 | §112 | Final Rejection | — | Pending | Jun 07, 2024 |
| 18694378 | CANNABIGEROQUINONE COMPOUNDS, COMPOSITIONS INCLUDING SUCH COMPOUNDS, AND USES OF SUCH COMPOUNDS AND COMPOSITIONS | PIHONAK, SARAH | 1627 | §101§102§103§112 | Final Rejection | — | Pending | Mar 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialJuva Life Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Connor Kennedy English has the most, with 1 of Juva Life Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
